[11] In May 2016 UDG Healthcare acquired Pegasus, an integrated healthcare communications consultancy. UDG has not had significant price volatility in the past 3 months. S&P does not guarantee the accuracy, adequacy, completeness or availability of any information and is not responsible for any errors or omissions, regardless of the cause or for the results obtained from the use of such information. Revenue vs Market: UDG's revenue (5.7% per year) is forecast to grow slower than the UK market (6.6% per year). Debt Coverage: UDG's debt is well covered by operating cash flow (68%). UDG's dividends in 3 years are forecast to be well covered by earnings (34.4% payout ratio). View the latest UDG Healthcare (UDG) share price and news, including recent trades, historical charts, broker views and our views. UDG Healthcare plc, together with its subsidiaries, provides advisory, communication, commercial, clinical, and packaging services in the Republic of Ireland, the United Kingdom, North America, and internationally. [citation needed], In January 2007, the company acquired Presearch, a UK laboratory services company, for GBP £2.9 million. More Details, Trading at 10.8% below our estimate of its fair value, Earnings are forecast to grow 12.17% per year, Earnings grew by 243.4% over the past year. UDG Healthcare plc is a global leader in healthcare advisory, communications, commercial, clinical and packaging services. PEG Ratio: UDG is poor value based on its PEG Ratio (2.3x). Explore more healthy companies in the Healthcare industry. UDG Healthcare provides clinical, commercial, communication and packaging services to the healthcare industry. ($USD2.79M) is above average for companies of similar size in the UK market ($USD2.12M). Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months. High Growth Earnings: UDG's earnings are forecast to grow, but not significantly. Notable Dividend: UDG's dividend (1.7%) isn’t notable compared to the bottom 25% of dividend payers in the UK market (1.8%). Reducing Debt: UDG's debt to equity ratio has reduced from 78% to 25.4% over the past 5 years. As of 2019, UDG Healthcare received an MSCI ESG Rating of AA. Earnings vs Savings Rate: UDG's forecast earnings growth (12.2% per year) is above the savings rate (1.2%). Compensation vs Market: Brendan's total compensation ($USD2.79M) is above average for companies of similar size in the UK market ($USD2.12M). This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. [8] In February 2014, the company made its largest acquisition when it bought KnowledgePoint360 which specializes in healthcare communications for €105 million and made it part of its Ashfield division. How experienced are the management team and are they aligned to shareholders interests? How is UDG Healthcare forecast to perform in the next 1 to 3 years based on estimates from 9 analysts? UDG Healthcare plc's company bio, employee growth, exchange listings and data sources, UDG Healthcare plc, together with its subsidiaries, provides advisory, communication, commercial, clinical, and packaging services in the Republic of Ireland, the United Kingdom, North America, and interna ... Show more. It is a constituent of the FTSE 250 Index. UDG's forecast earnings growth (12.2% per year) is above the. In no event shall S&P be liable for any direct, indirect, special or consequential damages, costs, expenses, legal fees, or losses (including lost income or lost profit and opportunity costs) in connection with subscriber’s or others’ use of S&P Capital IQ. UDG Healthcare plc, together with its subsidiaries, provides advisory, communication, commercial, clinical, and packaging services in the Republic of Ireland, the United Kingdom, North America, and interna, Unless specified all financial data is based on a yearly period but updated quarterly. High Dividend: UDG's dividend (1.7%) is low compared to the top 25% of dividend payers in the UK market (5.25%). Earnings vs Industry: UDG earnings growth over the past year (243.4%) exceeded the Healthcare industry -1.2%. Mr. McAtamney has been a Non-Executive Di ... Show more. Trading at 10.8% below our estimate of its fair value. The Ashfield segment offers commercialization and clinical services for the pharmaceutical and healthcare industry. High ROE: UDG's Return on Equity (9.5%) is considered low. Growing Profit Margin: UDG's current net profit margins (6.7%) are higher than last year (2%). [5] It acquired Pharmexx, a Frankfurt-based business, in July 2012. High Growth Revenue: UDG's revenue (5.7% per year) is forecast to grow slower than 20% per year. How has UDG Healthcare's share price performed over time and what events caused price changes? Flawless balance sheet with proven track record and pays a dividend. More Details. It is listed on the London Stock Exchange. [6] In September 2012 it decided to move its primary listing from Irish Stock Exchange to the London Stock Exchange. is forecast to be low in 3 years time (10.7%). Reproduction of S&P Capital IQ in any form is prohibited except with the prior written permission of S&P. (46.9%), UDG's dividend payments are well covered by earnings. Learn more. Explore growth companies in the Healthcare industry. Return vs Market: UDG exceeded the UK Market which returned -13.2% over the past year. What Can We Learn About UDG Healthcare's (LON:UDG) CEO Compensation? UDG's dividend (1.7%) is low compared to the top 25% of dividend payers in the UK market (5.25%). Stable Dividend: UDG's dividends per share have been stable in the past 10 years. Please visit our COVID-19 Response Centre for all the latest updates. Does UDG Healthcare (LON:UDG) Have A Healthy Balance Sheet? Sharp is a global leader in contract clinical, manufacturing, packaging and technology services. The Company operates through three segments: Ashfield, Sharp, and Aquilant. have bought more shares than they have sold in the past 3 months. Short Term Liabilities: UDG's short term assets ($573.3M) exceed its short term liabilities ($357.6M). UDG (£7.58) is trading below our estimate of, UDG is trading below fair value, but not by a. UDG's earnings have declined by 8.9% per year over the past 5 years. UDG's debt to equity ratio has reduced from 78% to 25.4% over the past 5 years. UDG exceeded the UK Healthcare industry which returned -2.7% over the past year. Earnings Trend: UDG's earnings have declined by 8.9% per year over the past 5 years. Learn more here. © 2020 UDG Healthcare plc. UDG Healthcare plc, formerly United Drug, is a Dublin-based international company and partner to the healthcare industry, providing clinical, commercial, communication and packaging services. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. PE vs Market: UDG is poor value based on its PE Ratio (27.5x) compared to the UK market (18.4x). Mr. McAtamney has been a Non-Executive Di. Compensation vs Earnings: Brendan's compensation has been consistent with company performance over the past year. Unless specified all financial data is based on a yearly period but updated quarterly. Explore potentially undervalued companies in the Healthcare industry. Who are the major shareholders and have insiders been buying or selling? UDG's earnings (12.2% per year) are forecast to grow slower than the UK market (24.5% per year). [7] It changed its name from United Drug to UDG Healthcare in October 2013. (2018). UDG exceeded the UK Market which returned -13.2% over the past year. [15], UDG Healthcare plc operates across two divisions: Ashfield and Sharp. UDG Healthcare plc (LON: UDG) is a leading international partner of choice delivering advisory, communication, commercial, clinical and packaging services to the healthcare industry, employing over 8,500 people with operations in 25 countries and delivering services in over 50 countries. Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. We build trust with our partners by delivering on our promises and we achieve our clients’ goals with energy and ingenuity. How has UDG Healthcare performed over the past 5 years? Brendan's compensation has been consistent with company performance over the past year. UDG Healthcare plc's (LON:UDG) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects? You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. UDG Healthcare plc, together with its subsidiaries, provides advisory, communication, commercial, clinical, and packaging services in the Republic of Ireland, the United Kingdom, North America, and internationally. [13] In July 2017, the company acquired Vynamic; later in the same month it acquired Cambridge BioMarketing for up to $35 million.[14]. No risks detected for UDG from our risk checks. [9][10], In September 2015, UDG Healthcare sold its Irish drug distribution businesses to McKesson Corporation for $466 million. Executive Vice President of Corporate Development, Global Head of Marketing and Communications, Uk Head of Syndicated Services for Ashfield, Global President of Advisory Services & Business Development.

The Banff Springs Hotel History, Battle Of The Bulge Game Pc, Terraforming Earth Game, Cold Cold Cold Tab, The Outer Limits Season 1 Episode 8, Cressbrook Dam Level,